Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "The European MCL Network R2 Elderly Trial - R2 vs. R Maintenance After 1L Chemoimmunotherapy in Elderly MCL Patients"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Vincent Ribrag
By
Insights from 2023 ASH Annual Meeting
FEATURING
Vincent Ribrag
Login to view comments.
Click here to Login